Surgery Partners - SGRY Stock Forecast, Price & News

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Royal Bank of Canada dropped their price objective on shares of Surgery Partners from $65.00 to $62.00 and set an "outperform" rating on the stock in a research note on Wednesday. Citigroup lifted their target price on shares of Surgery Partners from $61.00 to $64.00 in a report on Wednesday, May 4th. StockNews.com cut shares of Surgery Partners from a "hold" rating to a "sell" rating in a report on Tuesday, July 26th. Bank of America cut shares of Surgery Partners from a "buy" rating to a "neutral" rating and decreased their target price for the stock from $55.00 to $36.00 in a report on Wednesday, June 15th. Finally, Benchmark lifted their target price on shares of Surgery Partners from $65.00 to $72.00 in a report on Wednesday, May 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Surgery Partners presently has an average rating of "Hold" and a consensus target price of $58.67.

Surgery Partners Stock Up 2.5 %

SGRY opened at $36.90 on Friday. The company has a quick ratio of 1.61, a current ratio of 1.51 and a debt-to-equity ratio of 1.48. The firm has a 50 day moving average price of $33.85 and a 200-day moving average price of $44.22. Surgery Partners has a twelve month low of $26.66 and a twelve month high of $63.87. The stock has a market capitalization of $3.32 billion, a price-to-earnings ratio of -105.43, a PEG ratio of 12.99 and a beta of 2.87.

Insider Activity

In other news, insider George Goodwin sold 12,586 shares of the business's stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $40.00, for a total transaction of $503,440.00. Following the completion of the transaction, the insider now directly owns 31,806 shares of the company's stock, valued at $1,272,240. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 26,380 shares of company stock valued at $1,053,599 over the last three months. Insiders own 3.30% of the company's stock.